Lipoprotein(a), or Lp(a), has emerged as a genetically determined, independent, and causal risk factor for atherosclerotic cardiovascular disease (ASCVD) and calcific aortic valve stenosis. Despite its established clinical relevance, Lp(a) remains underrecognized and undertested in routine practice. This Advances in™...